Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Inhaled Corticosteroids Versus Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/repview. Accessed 27 April 2024.
Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/repview. Accessed April 27, 2024.
Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/repview
Inhaled Corticosteroids Versus Long‐acting Beta2‐agonists for Chronic Obstructive Pulmonary Disease [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Inhaled corticosteroids versus long‐acting beta2‐agonists for chronic obstructive pulmonary disease
ID - 431603
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431603/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -